$ALDX

Aldeyra Therapeutics, Inc.

Nasdaq · Healthcare · Pharmaceutical Preparations · Concord, MA

ALDX chart

What traders are saying about $ALDX

Latest posts

Aldeyra Therapeutics, Inc. news

Aldeyra Therapeutics, Inc. key financials

USD2025202420232022
Net income-$33.8M-$55.9M-$37.5M-$62.0M
Diluted EPS$-0.56$-0.94$-0.64$-1.06
Total assets (year end)$72.1M$104.6M$148.3M$181.3M
Cash and equivalents (year end)$70.0M$54.5M–$144.4M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Aldeyra Therapeutics, Inc.

Ticker
ALDX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Concord, MA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1341235
Former names
Aldexa Therapeutics, Inc., Neuron Systems Inc

Frequently asked questions

What exchange is Aldeyra Therapeutics, Inc. listed on?

Aldeyra Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ALDX.

What industry is Aldeyra Therapeutics, Inc. in?

Aldeyra Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Aldeyra Therapeutics, Inc. headquartered?

Aldeyra Therapeutics, Inc.'s business address on file with the SEC is in Concord, MA.

When does Aldeyra Therapeutics, Inc.'s fiscal year end?

Aldeyra Therapeutics, Inc.'s fiscal year ends on December 31.